Starting a CRO on personal credit

Written by Afshin Safavi, Founder & Chief Scientific Officer, BioAgilytix

AIdriven research projecting new drug developments, Pharmaceutical technology, Innovating medicine with advanced predictive analytics

Afshin Safavi is a veteran biochemist with extensive experience establishing and leading bioanalytical teams in pharmaceutical, biotechnology, and manufacturing companies, as well as CROs. He and his teams have supported the development of a broad range of therapeutics in pre-clinical and clinical-trial laboratories. Prior to founding BioAgilytix, he was the Director of Ligand Binding and Immunoassay, operating under GLP at AAIPharma. At Talecris BioTherapeutics, he led the Preclinical and Clinical Assay Development team, building on his experience as a senior scientist at Nobex Corporation, GlaxoSmithKline and IGEN International. Safavi is considered an expert in the area of immunoassays, with a...

To view this content, please register now for access

It's completely free